Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Citi
Boehringer Ingelheim
Julphar
Mallinckrodt
Novartis
Accenture
QuintilesIMS
UBS
Cipla

Generated: August 24, 2017

DrugPatentWatch Database Preview

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Amlodipine Besylate And Benazepril Hydrochloride, and what generic Amlodipine Besylate And Benazepril Hydrochloride alternatives are available?

Amlodipine Besylate And Benazepril Hydrochloride is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Mylan, Dr Reddys Labs Inc, Watson Labs Inc, Lupin Pharms, Teva Pharms, Par Pharm, and Watson Labs. and is included in eleven NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.

Summary for Tradename: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Patents:0
Applicants:9
NDAs:11
Suppliers / Packagers: see list18
Clinical Trials: see list105,850
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077183-001Apr 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077179-005Jul 5, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077890-001Oct 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077375-004May 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077179-004May 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077179-001May 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL091431-001Dec 30, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL090364-002Jul 5, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL078466-006Jul 5, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL078381-004Jul 29, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Covington
Teva
AstraZeneca
Chinese Patent Office
Argus Health
Dow
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot